Delivery Order SPE2DB22D2006-SPE2DB24FW0GA
Award Date 5/10/24
Potential Completion Date 5/13/24
Potential Value $1.7K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order contract valued at $2,325.36 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of ENGERIX-B 20 MCG/ML SYRNML, a pharmaceutical product, with a performance period ending on May 15, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a range of...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract worth $1,052.41 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. This order is for the supply of ENGERIX-B 20 MCG/ML SYRNML, a pharmaceutical product. The contract has a completion date of February 9, 2024 and was awarded on February 8, 2024. Amerisourcebergen Drug Corp is the prime contractor for this delivery order, which is not associated with any...
- The Defense Logistics Agency (DLA) awarded a $3,195.31 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of ENGERIX-B 20 MCG/ML SYRNML pharmaceutical products. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The delivery order is for the supply of ENGERIX-B 20 MCG/ML SYRNML, a pharmaceutical product, with a potential value of $1,176.68 and a completion date of February 23, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corporation's Corporate Office Division to provide ENGERIX-B 20 MCG/ML SYRNML, a pharmaceutical product, for $16,606.00. The order has a firm-fixed price and a completion date of July 9, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the federal government, with a focus on serving the Department of Defense (DoD) and Veterans Affairs (VA) healthcare...
- The Defense Logistics Agency awarded a firm fixed price delivery order contract valued at $5,850.10 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of ENGERIX-B 20 MCG/ML SYRNML pharmaceutical product. This delivery order is part of an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that was awarded solely to Amerisourcebergen Drug Corp. The IDC serves as the primary contract vehicle for Amerisourcebergen to deliver...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office division. The contract, valued at $1,294.13, is for the delivery of ENGERIX-B 20 MCG/ML VIALML, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of August 28, 2024. AmerisourceBergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, has been awarded...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, is for the delivery of the medication ENGERIX-B 20 MCG/ML VIALML. The $2,056.29 firm fixed price delivery order was issued by the Medical Supply Chain of the Defense Logistics Agency (DLA). The contract has an ultimate completion date of February 14, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide ENGERIX-B 20 MCG/ML SYRNML, a pharmaceutical product, with a potential value of $2,685.51 and a completion date of February 12, 2024. This award is not associated with any set-aside designations. Amerisourcebergen Drug Corp is the prime contractor and holds an indefinite delivery contract (IDC) with DLA, valued up...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ENGERIX-B 20 MCG/ML SYRNML, a pharmaceutical product, with a ceiling value of $2,408.46 and a period of performance through May 9, 2025. The contract is a Firm Fixed Price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a larger Indefinite...